Welcome to the patient access section
Information for ovarian cancer patients.
Thank you for your interest in Prima BioMed's clinical trial of Cvac™,
an experimental vaccine treatment which may prevent recurrence of
ovarian cancer in patients whose disease is in remission after surgery
and/or chemotherapy. If you are a patient recently in remission after
first or second line chemotherapy, this brief trial outline may be
helpful for you. More information is available on the US Government
Clinical Trials website. The study is recruiting patients at multiple sites in Australia and the United States
|
|